Fludiazepam, marketed under the brand name Erispan, is a potent benzodiazepine and 2ʹ-fluoro derivative of diazepam.
Refer to Difludiazepam.
It was originally developed by Hoffman-La Roche in the 1960s.
It is marketed in Japan and Taiwan. It exerts its pharmacological properties via enhancement of GABAergic inhibition.
Fludiazepam has 4 times more binding affinity for benzodiazepine receptors than diazepam. It possesses anxiolytic, anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties. Fludiazepam has been used recreationally.
You must be logged in to post a comment.